During the past decade, Universitätsklinikum Münster; Augenheilkunde conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Münster; Augenheilkunde" are "Geographic Atrophy" (3 trials), "Diabetic Macular Edema" (2 trials), "Neovascular Age-related Macular Degeneration" (1 trials), "Neovascular Age-related Macular Degeneration (nAMD)" (1 trials) and "Wet Macular Degeneration" (1 trials). Many other conditions were trialed in "Universitätsklinikum Münster; Augenheilkunde" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Münster; Augenheilkunde" are "Drug" (7 trials), "Other" (4 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (4 trials), "Sham Procedure" (4 trials), "Aflibercept" (2 trials), "Lampalizumab" (2 trials) and "No intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Münster; Augenheilkunde" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Münster; Augenheilkunde". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universitätsklinikum Münster; Augenheilkunde, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Münster; Augenheilkunde, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".